Lina Meng, PharmD
@linameng.bsky.social did:plc:ycw7p4gsmriv6yll3dwgwqrb
ID Pharmacist | Antimicrobial Stewardship Team | Stanford Health Care, CA | #MedEd #handshakestewardship I love pugs, 🏐, and travel, but actually spend most of my free time figuring out parenting of young kids🪇
Bei Bluesky seit
- Follower
- 1.083
- Folgt
- 281
- Posts
- 37
- Tage in Ranglisten
- 0
Zusammenfassung
Lina Meng, PharmD (@linameng.bsky.social) ist seit 13 November 2024 auf Bluesky. Das Konto hat 1.083 Follower, folgt 281 Konten und hat 37 Posts veröffentlicht.
Ranglisten-Platzierungen
Die besten Tage, an denen Posts dieses Kontos in Debyas Tagesliste kamen.
Dieses Konto war noch in keiner Tagesrangliste.
Zuletzt gelikte Posts
Öffentliche Likes aus dem Bluesky-Netzwerk.
📣 New #Communicable / #Breakpoints drops Mon 21 Sep! Erin McCreary, PharmD & Josh Davis are joined by Steve Webb & Steven Tong to discuss REMAP-CAP results suggesting that oseltamivir may harm critically ill patients, while also highlighting the importance and impact of RCTs. #IDSky #ViroSky #flu
Post anzeigenExclusive: Unedited footage from the multidisciplinary Heart Team meeting (interventional cardiologists versus cardiac surgeons):
Post anzeigenEffect of quinolone prophylaxis discontinuation during pre-engraftment neutropenia on incidence, mortality, and aetiology of bloodstream infections in hematopoietic stem-cell transplant recipients: a systematic review and meta-analysis 🔁 Repost 🔗 https://t.co/SRZ5pgzuPl
Post anzeigenA novel RNA nucleic acid amplification test more accurately distinguishes active Clostridioides difficile infection from colonization 🔁 Repost 🔗 https://t.co/bNzap1do5x
Post anzeigenSome of our ID fellows spent a day surfing in Santa Cruz! Mark Lieber, Christina Lin, Vanessa Gow-Lee, and Annika Bergstrom were joined by Michelle Nguyen and Frankie Garcia for a day off the wards. Considering our program? This could be part of your future here too!
Post anzeigen
Blockierte Konten
Blockierungen sind auf Bluesky öffentlich.
Dieses Konto blockiert niemanden.